
Scientists have found evidence that explosive concentric muscle contractions may help optimise the capacity for weight loss through resistance training.
The new finding is a result of the efforts of Dr. Scott Mazzetti, Health, Physical Education and Human Performance faculty at Salisbury University.
Advertisement
Co-authored with faculty from Anderson and Ball State Universities, an article on the findings has been published in the journal Medicine and Science in Sports and Exercise.
The researchers explored the effects of explosive verses slow contractions and exercise intensity on energy expenditure in their study.
The study showed that explosive or more rapid muscle contractions used more energy than slow contractions, even when the amount of weight lifted was identical, increasing the benefits of the exercise for weight loss.
It also demonstrated that explosive contractions were more effective in increasing energy expenditure when using moderate weight loads instead of heavy loads.
Source: ANI
SRM/J
The study showed that explosive or more rapid muscle contractions used more energy than slow contractions, even when the amount of weight lifted was identical, increasing the benefits of the exercise for weight loss.
It also demonstrated that explosive contractions were more effective in increasing energy expenditure when using moderate weight loads instead of heavy loads.
Source: ANI
SRM/J
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News

South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.

Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.

By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.

Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.

Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.